Saturday 17 October 2026
Export IRON’s income statement to Excel — free account
Disc Medicine, Inc.
IRON Healthcare Biotechnology
In the quarter to June 2026, EPS grew 2.53%, free cash flow grew 7.83% and total debt rose 106.5%, each against the same quarter a year earlier.
56.80
0.15
+0.26%
Follow IRON
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| (39.08%) | (35.83%) | (35.86%) | (34.78%) |
+8 more TTM periods Free account |
|
| (35.12%) | (33.11%) | (32.55%) | (32.18%) | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
(34.96%) | (33.68%) | (27.61%) | (30.10%) | |
Free Cash Flow per Share |
(5.11) | (5.23) | (5.14) | (4.72) | |
Free Cash Flow |
(197.54) | (201.25) | (181.33) | (166.03) | |
Capital Expenditures |
— | — | (0.93) | (1.36) | |
| Other line items | |||||
Cash ROIC |
(13.90%) | (13.90%) | (11.62%) | (13.63%) | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Interest Coverage |
(75.81) | (74.73) | (65.43) | (26.91) | |
Operating CF/Net income |
0.80 | 0.83 | 0.85 | 0.91 | |
Depreciation/Fixed assets |
(4.67) | (6.27) | (7.11) | (7.25) | |
Capex/Depreciation |
0.00 | 0.00 | 0.11 | 0.15 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(5.11) | (5.23) | (5.11) | (4.68) | |
Capex per Share |
0.00 | 0.00 | (0.03) | (0.04) | |
Capex to Sales |
— | — | 0.00 | 0.00 |
Columns are period end dates